This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Mitsubishi Tanabe Pharma Corporation. Active years: 2009-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2012
Title: Taketoshi Ishii: Innovator in Parkinson's Disease Treatment
Introduction
Taketoshi Ishii is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurological disorders. With a focus on innovative therapeutic methods, Ishii has been instrumental in advancing medical science.
Latest Patents
Ishii holds 2 patents that showcase his groundbreaking work. His latest patents include a method for treating Parkinson's disease through the administration of a phosphodiesterase 10 inhibitor. This invention not only provides a therapeutic approach for Parkinson's disease but also enhances dopamine signaling in the brain. Additionally, he has developed a novel piperidine compound that offers potential benefits in treating various conditions.
Career Highlights
Ishii is associated with Mitsubishi Tanabe Pharma Corporation, where he continues to innovate and contribute to the pharmaceutical industry. His work has garnered attention for its potential to improve the quality of life for individuals suffering from Parkinson's disease.
Collaborations
Ishii has collaborated with notable colleagues, including Masami Takahashi and Tsutomu Miyake. These partnerships have further enriched his research and development efforts.
Conclusion
Taketoshi Ishii's contributions to the treatment of Parkinson's disease and his innovative approach to pharmaceutical development highlight his importance in the field. His work continues to inspire advancements in medical science and offers hope for those affected by neurological disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
